ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02504372
Brief Title: Study of Pembrolizumab (MK-3475) vs Placebo for Participants With Non-small Cell Lung Cancer After Resection With or Without Standard Adjuvant Therapy (MK-3475-091/KEYNOTE-091) (PEARLS)

First Submitted : July 20, 2015
First Submitted that Met QC Criteria : July 20, 2015
First Posted : July 21, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : September 10, 2018
Last Update Posted : September 12, 2018